
HCA Healthcare, Inc. (NYSE:HCA – Free Report) – Leerink Partnrs boosted their FY2025 earnings per share estimates for HCA Healthcare in a report issued on Monday, October 27th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $27.69 per share for the year, up from their prior forecast of $26.75. The consensus estimate for HCA Healthcare’s current full-year earnings is $24.98 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q1 2026 earnings at $7.23 EPS, Q2 2026 earnings at $7.71 EPS, Q3 2026 earnings at $7.88 EPS and Q4 2026 earnings at $8.39 EPS.
Other analysts also recently issued reports about the company. Barclays boosted their target price on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research report on Monday. Stephens boosted their price objective on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $417.00 price target on shares of HCA Healthcare in a report on Monday. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research note on Monday. Finally, Jefferies Financial Group upped their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $473.53.
HCA Healthcare Price Performance
HCA opened at $466.44 on Thursday. The stock has a market cap of $109.14 billion, a P/E ratio of 18.03, a P/E/G ratio of 1.38 and a beta of 1.40. The stock’s 50 day simple moving average is $420.00 and its 200 day simple moving average is $385.66. HCA Healthcare has a 1-year low of $289.98 and a 1-year high of $478.19.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS.
Hedge Funds Weigh In On HCA Healthcare
Hedge funds and other institutional investors have recently modified their holdings of the company. Cheviot Value Management LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at about $26,000. Saudi Central Bank acquired a new position in HCA Healthcare during the first quarter valued at approximately $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare during the 1st quarter valued at $27,000. Ameriflex Group Inc. acquired a new position in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC acquired a new position in shares of HCA Healthcare during the second quarter worth about $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by company insiders.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More
- Five stocks we like better than HCA Healthcare
- Should You Invest in Penny Stocks?
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- How to trade penny stocks: A step-by-step guide
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
